ENOV News and Press, Enovis Corporation From 06/07/22

Diamond Hill invests on behalf of clients through a shared commitment to its valuation-driven investment principles, long-term perspective, capacity discipline and client alignment. Amid a rocky market quarter overall, Diamond Hill Mid Cap Fund's negative returns still outpaced the Ru...

Wilmington, DE, June 06, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference on Monday, June 13, 202...

Diamond Hill invests on behalf of clients through a shared commitment to its valuation-driven investment principles, long-term perspective, capacity discipline and client alignment. Amid a rocky market quarter overall, our portfolio’s negative returns still outpaced the Russell...

Enovis has been the medtech segment which remained following the spin-off from Colfax. The standalone business has some to prove, as margins need a boost to create appeal here. I think that the valuations here are too demanding, preferring the welding ESAB business. For furt...

ESAB is the welding business which has been spun off from its former parent, called Colfax. After cutting the 2022 guidance, I still find confidence in a solid strategy even after 2022 is set to be a rockier year, while spin-offs face inherent uncertainty. Amidst non-demanding val...

The following slide deck was published by Enovis Corporation in conjunction with their 2022 Q1 earnings call. For further details see: Enovis Corporation 2022 Q1 - Results - Earnings Call Presentation

Enovis Corporation (ENOV) Q1 2022 Earnings Conference Call May 10, 2022 08:00 AM ET Company Participants Christopher Hix - Executive Vice President & Chief Financial Officer Matthew Trerotola - Chief Executive Officer Conference Call Participants Jeff Johnson - Robert W. Baird & Co. M...

Enovis Corporation press release (NYSE:ENOV): Q1 GAAP EPS of $0.33. Revenue of $1.02B (+16.0% Y/Y). For further details see: Enovis Corporation GAAP EPS of $0.33, revenue of $1.02B

Wilmington, DE, May 10, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced its adjusted stand-alone financial results for the first quarter of 2022.   At the beginni...

Enovis Corporation (NYSE:ENOV) is scheduled to announce Q1 earnings results on Tuesday, May 10th, before market open. The consensus EPS Estimate is $0.35 (-20.5% Y/Y) and the consensus Revenue Estimate is $367.4M (-58.2% Y/Y). Over the last 2 years, ENOV has beaten EPS estimates 100% of the t...